Donald Hooker

Shares of Teladoc Health, Inc. (NYSE: TDOC) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter. The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100....

Quest Diagnostics Inc (NYSE: DGX) announced Wednesday it had received an emergency use authorization from the Food and Drug Administration for a new laboratory technique that can help signficantly expand and speed up novel coronavirus (COVID-19) testing. What Happened The...

Quest Diagnostics Inc (NYSE: DGX) is generating estimated earnings of around $1 per share from COVID-19 lab tests and the Public Health Emergency declaration could continue well into 2021, according to KeyBanc Capital Markets. The Quest Diagnostics Analyst: Donald Hooker upgraded Quest Diagnostics...

Phreesia Inc’s (NYSE: PHR) stock is a way for investors to gain exposure to growing health care consumerism in the United States, according to KeyBanc Capital Markets. The Analyst KeyBanc’s Donald Hooker initiated coverage of Phreesia with an Overweight rating and a price target of $36...

HealthEquity Inc (NASDAQ: HQY) outperformed third-quarter expectations with a 47-cent bottom-line more than double analyst forecasts. Revenue of $157.1 million also beat consensus estimates of $152.4 million, while EBITDA closed the quarter at $56 million against $43 million forecasts....

KeyBanc Capital Market's bull case for Catalent Inc (NYSE: CTLT) has come to an end. The company has taken the necessary steps to gain exposure to the high-growth biologics and gene therapy space, according to the sell-side firm.  The Analyst Donald Hooker downgraded Catalent from...

Inovalon Holdings Inc (NASDAQ: INOV) has reported several quarters of strong bookings and appears poised to deliver positive financial surprises going ahead, after years of posting disappointing results, according to KeyBanc Capital Markets. The Analyst KeyBanc’s Donald Hooker upgraded...

Livongo Health Inc (NASDAQ: LVGO) shares have bumped up more than 30% since the company went public at the end of July, raising interest in the digital health platform company. But analysts’ opinions were mixed as two firms started coverage on Monday. The Analysts KeyBanc Capital Market's...

Charles River Laboratories Intl. Inc (NYSE: CRL), a preclinical and clinical laboratory service provider to the pharmaceutical, medical device and biotechnology industries, is "by far" an industry leader, according to KeyBanc Capital Markets.  The Analyst Analyst Donald Hooker...

Laboratory Corp. of America Holdings (NYSE: LH) and Quest Diagnostics Inc (NYSE: DGX) could benefit from a "significant wave" of consolidation in the lab testing and diagnostics sector, according to KeyBanc Capital Markets.  The Analyst Analyst Donald Hooker upgraded Laboratory...

Catalent Inc (NYSE: CTLT) is poised to grow revenue by 6 percent and adjusted EBITDA by 8-10 percent through 2020, according to KeyBanc Capital Markets.  The Analyst Analyst Donald Hooker upgraded shares of Catalent from Sector Weight to Overweight with a $48 price target. The Thesis...

Checks at the recent Health Care Information and Management Systems Society conference and follow-up discussions with Teladoc Inc (NYSE: TDOC) have made KeyBanc Capital Markets incrementally positive on the company, the firm said in a Wednesday note.  The Analyst Analyst Donald Hooker...

Iqvia Holdings Inc (NYSE: Q), formerly known as Quintiles, merged with IMS Health last year to combine its data assets and tools to better compete in the post-Cures Act environment. The Analyst KeyBanc Capital Markets' Donald Hooker downgraded Iqvia's stock rating from Overweight to...

KeyBanc Capital’s Donald Hooker expects the Investor Summit hosted by athenahealth, Inc (NASDAQ: ATHN) on December 15 to include discussions on two “promising” verticals, hospitals and population health management. Hooker maintains a Sector Weight rating on the company....